Germany's CureVac is on track to file for European approval of the company's Covid-19 vaccine as early as this month because high infection rates among trial...
The euro is showing little movement on Wednesday. In the North American session, EUR/USD is trading at 1.2005, down 0.06% on the day. Services PMI show...
It’s time to take what the UK has learnt about the “Holy Trinity” of government, academia, and industry The post Creating a global life sciences superpower...
Stocks Tumble As White House Backs WTO Plan To Waive IP Protections For COVID Vaccines In a major rebuke to the west's biggest vaccine makers (including...
New US COVID Cases Tumble Despite 25% Drop In Daily Vaccinations Following almost two months of roughly flat-lining new Covid cases in the US, we are...
Pfizer announced that it expects to earn around 26 billion dollars from the sale of its vaccine against Covid-19 this year.
President Joe Biden on May 4 announced a goal to vaccinate 70 percent of U.S. adults with at least one Covid-19 shot by the July 4...
An imperfectly applied risk model led to the devastating situation India is facing today.
The BEA announced the advance estimate for Q1 GDP showing an increase of 6.39%. The increase was largely fueled by a massive increase in in consumption...
Overview: Disappointing German, French, and Italian PMI reports helped send the euro to almost $1.1985, its lowest level in about two and a half weeks, and...
Skillz Inc. (SKLZ) reported a wider-than-expected loss in the first quarter, impacted by elevated costs and expenses. Shares of the online mobile video game platform declined...
Pfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it The post Pfizer says COVID-19 jab could rake...
From Mind Control To Viruses: How The Government Keeps Experimenting On Its Citizens Authored by John W. Whitehead & Nisha Whitehead via The Rutherford Institute, “They...
CNBC Exclusive: CNBC Transcript: Pfizer Inc. (NYSE:PFE) Chairman and CEO Albert Bourla Speaks with CNBC’s “The Exchange” Today Q1 2021 hedge fund letters, conferences and more...
Thailand, Laos Report Surging COVID Cases As India's Outbreaks Spreads Across Asia Just as the WHO feared, India's brutal second wave has spilled over its borders,...
"Use It Or Lose It" - New White House Policy Pressures States To Ensure Vaccine Adoption As states resort to cash rewards and other tactics to...
Lyft Soars After Beating Estimates; On Verge Of Cashflow Breakeven With the world slowly emerging from the covid pandemic, ridesharing services are seeing an impressive return...
McMaken: Vaccine Passports Are Just A Way For The Regime To Expand Its Power Authored by Ryan McMaken via The Mises Institute, Earlier this month, the...
Best penny stocks to watch in 2021? Here are 3 for your long term watchlist The post Trending Penny Stocks To Watch in 2021? Take a...
The Biden administration is busy burnishing America’s global credentials. The U.S. Treasury wants an international approach to corporate tax. Meanwhile, climate change talks with other governments...
President Joe Biden will announce a goal on May 4 to have 70 percent of U.S. adults vaccinated with at least one Covid-19 shot and 160...
Pfizer (PFE) posted better-than-expected 1Q results driven by strong business performance and contributions from BNT162b2, the Pfizer COVID-19 vaccine. Meanwhile, the pharmaceutical company lifted its revenue...
Next year, people are likely to need an annual Covid-19 vaccination just like they need an annual flu shot. That prediction is made by researchers at...
BioNTech is working on getting approval for a version of the company's Covid-19 vaccine which can be stored in fridges of 2 to 8 degree celsius...
U.S. export restrictions on key materials are making it impossible to predict the CureVac's short-term supply ramp-up in Europe.
Pfizer reported first-quarter 2021 revenue of $14.6 billion, an impressive 42 percent operational growth. The company's Covid-19 vaccine revenue accounted for $3.5 billion of the total.
- by New Deal democratWhile there has been some renewed DOOOMishness in the press about whether the US will ever reach “herd immunity” or not, I...
Last year, Sherlock Biosciences’ CRISPR-based COVID test launched CRISPR into healthcare as the first EUA approval for any CRISPR product—diagnostic or therapeutic. GEN spoke with Rahul...
Professor Winfried Just creates critical discussions around COVID in new book Credit: World Scientific Ohio University mathematics professor Winfried Just’s new book COVID-19: Unmasked – The...
Joe Nicholson-USA TODAY SportsMonday was a rough one as two high profile players went down with serious injuries. The MLB Daily Dish is a daily feature...